AM-301

· Altamira Medica Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AM-301, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers [NA]